Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM5 | P08912 | 1/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CHKA | P35790 | 1/20 | 0.33 |
| ▸ | MMP3 | P08254 | 1/20 | 0.33 |
| ▸ | BIRC2 | Q13490 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3795193 | 0.79 | CA2 (0.38) | CHRM5CHRM3CA2CHKAALDH1A1 | |
| SCHEMBL44272 | 0.79 | CA2 (0.38) | CHRM5CHRM3CA2CHKAALDH1A1 | |
| SCHEMBL3237370 | 0.78 | L3MBTL1 (0.39) | CHRM5CHRM3CA2CHKAALDH1A1 | |
| SCHEMBL28190985 | 0.76 | — | — | |
| SCHEMBL12534297 | 0.72 | CHRM5 (0.36) | CHRM5CHRM3ALDH1A1 | |
| Carbamic Acid SCHEMBL3170790 | 0.72 | SMN1; SMN2 (0.32) | CA2CHKAMMP3 | |
| SCHEMBL13070544 | 0.70 | — | — | |
| SCHEMBL27632519 | 0.69 | MAPT (0.50) | CA2CHKAALDH1A1 | |
| SCHEMBL13100975 | 0.69 | — | — | |
| SCHEMBL15824158 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8853133-B2 | Analyte determination utilizing mass tagging reagents comprising a non-encoded detectable label | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. (SG) | 2014-10-07 | — | — | US | disclosed |
| US-8853133-B2 | Analyte determination utilizing mass tagging reagents comprising a non-encoded detectable label | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. (SG) | 2014-10-07 | — | — | US | disclosed |
| US-8492163-B2 | Methods, mixtures, kits and compositions pertaining to analyte determination | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. (SG) | 2013-07-23 | — | — | US | disclosed |
| US-20130184181-A1 | ANALYTE DETERMINATION UTILIZING MASS TAGGING REAGENTS COMPRISING A NON-ENCODED DETECTABLE LABEL | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. | 2013-07-18 | — | — | US | disclosed |
| US-20130184181-A1 | ANALYTE DETERMINATION UTILIZING MASS TAGGING REAGENTS COMPRISING A NON-ENCODED DETECTABLE LABEL | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. | 2013-07-18 | — | — | US | disclosed |
| US-8362242-B2 | Analyte determination utilizing mass tagging reagents comprising a non-encoded detectable label | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. (SG) | 2013-01-29 | — | — | US | disclosed |
| US-20120196378-A1 | Methods, Mixtures, Kits and Compositions Pertaining to Analyte Determination | DH TECHNOLOGIES DEVELOPMNET PTE LTD. (SI) | 2012-08-02 | — | — | US | disclosed |
| US-7906341-B2 | Isobaric sets, mass differential labeling sets; mass spectrometry | DH TECHNOLOGIES DEVELOPMENT PTE, LTD. (SG) | 2011-03-15 | — | — | US | disclosed |
| US-20110028685-A1 | Analyte Determination Utilizing Mass Tagging Reagents Comprising A Non-Encoded Detectable Label | APPLERA CORPORATION. (US) | 2011-02-03 | — | — | US | disclosed |
| US-20080241955-A1 | Methods, Mixtures, Kits And Compositions Pertaining To Analyte Determination | APPLERA CORPORATION (US) | 2008-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110028685-A1 | Analyte Determination Utilizing Mass Tagging Reagents Comprising A Non-Encoded Detectable Label | SRMS, KLK3, CNDP2 | CHRM5 2796/4885CHRM3 3007/4885CA2 3722/4885 |
| US-20080241955-A1 | Methods, Mixtures, Kits And Compositions Pertaining To Analyte Determination | SRMS, KLK3, MPO | CHRM5 1444/4885CHRM3 1958/4885CA2 1006/4885 |
| US-20120196378-A1 | Methods, Mixtures, Kits and Compositions Pertaining to Analyte Determination | SRMS, KLK3, MPO | CHRM5 1444/4885CHRM3 1958/4885CA2 1006/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.